Ronald Vagnozzi
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 23 | 2026 | 546 | 3.590 |
Why?
| | Myocardium | 13 | 2026 | 934 | 1.830 |
Why?
| | Fibrosis | 14 | 2026 | 559 | 1.610 |
Why?
| | Macrophages | 12 | 2026 | 1507 | 1.580 |
Why?
| | Ventricular Remodeling | 12 | 2026 | 278 | 1.330 |
Why?
| | Myocardial Infarction | 11 | 2026 | 1210 | 1.320 |
Why?
| | Cell- and Tissue-Based Therapy | 2 | 2021 | 78 | 1.250 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 189 | 1.180 |
Why?
| | Adult Stem Cells | 2 | 2018 | 40 | 1.100 |
Why?
| | Immunity, Innate | 3 | 2021 | 835 | 0.940 |
Why?
| | Homeostasis | 4 | 2026 | 642 | 0.930 |
Why?
| | Biomedical Research | 2 | 2024 | 717 | 0.890 |
Why?
| | Cell Differentiation | 8 | 2024 | 2046 | 0.790 |
Why?
| | Cardiomyopathies | 3 | 2023 | 335 | 0.760 |
Why?
| | Myofibroblasts | 6 | 2024 | 148 | 0.760 |
Why?
| | Sirtuin 3 | 1 | 2023 | 60 | 0.750 |
Why?
| | Heart | 5 | 2020 | 626 | 0.740 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1996 | 0.730 |
Why?
| | American Heart Association | 1 | 2024 | 358 | 0.720 |
Why?
| | Cardiomyopathy, Restrictive | 1 | 2021 | 11 | 0.690 |
Why?
| | Monocytes | 2 | 2020 | 539 | 0.650 |
Why?
| | Immunity, Humoral | 1 | 2021 | 118 | 0.630 |
Why?
| | Myocarditis | 1 | 2021 | 102 | 0.620 |
Why?
| | Myeloid Cells | 1 | 2020 | 147 | 0.600 |
Why?
| | Animals | 46 | 2026 | 38030 | 0.590 |
Why?
| | Immunity, Cellular | 1 | 2021 | 274 | 0.590 |
Why?
| | Antigens, Ly | 1 | 2018 | 45 | 0.570 |
Why?
| | Mice | 35 | 2026 | 18329 | 0.570 |
Why?
| | Congresses as Topic | 1 | 2019 | 223 | 0.540 |
Why?
| | Running | 1 | 2020 | 233 | 0.540 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 285 | 0.530 |
Why?
| | Fibroblasts | 6 | 2026 | 1025 | 0.520 |
Why?
| | Immunotherapy | 1 | 2022 | 666 | 0.500 |
Why?
| | Immunotherapy, Adoptive | 1 | 2019 | 342 | 0.460 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 673 | 0.460 |
Why?
| | Glycogen Synthase Kinase 3 | 5 | 2014 | 83 | 0.460 |
Why?
| | Stem Cells | 1 | 2019 | 628 | 0.440 |
Why?
| | Membrane Proteins | 2 | 2018 | 1164 | 0.440 |
Why?
| | Disease Models, Animal | 12 | 2024 | 4560 | 0.410 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2013 | 70 | 0.390 |
Why?
| | Extracellular Matrix | 6 | 2021 | 562 | 0.380 |
Why?
| | Cell Cycle Proteins | 3 | 2026 | 630 | 0.380 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2187 | 0.380 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 956 | 0.370 |
Why?
| | Mice, Inbred C57BL | 17 | 2026 | 5983 | 0.360 |
Why?
| | Heart Failure | 6 | 2026 | 2326 | 0.360 |
Why?
| | Nuclear Proteins | 3 | 2026 | 740 | 0.360 |
Why?
| | Protein Kinases | 1 | 2013 | 312 | 0.350 |
Why?
| | Gene Deletion | 5 | 2017 | 391 | 0.330 |
Why?
| | Cell Communication | 2 | 2024 | 328 | 0.330 |
Why?
| | Rodentia | 2 | 2021 | 61 | 0.320 |
Why?
| | Mice, Transgenic | 10 | 2023 | 2188 | 0.320 |
Why?
| | Aging | 5 | 2020 | 1969 | 0.320 |
Why?
| | Transcription Factors | 4 | 2026 | 1734 | 0.300 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2024 | 139 | 0.290 |
Why?
| | Cell Lineage | 4 | 2020 | 377 | 0.280 |
Why?
| | Regeneration | 4 | 2020 | 197 | 0.280 |
Why?
| | Coronary Vessels | 2 | 2021 | 246 | 0.270 |
Why?
| | Mitochondria | 5 | 2020 | 992 | 0.250 |
Why?
| | Oxidative Stress | 1 | 2013 | 1356 | 0.250 |
Why?
| | Myocardial Contraction | 4 | 2015 | 293 | 0.240 |
Why?
| | Cells, Cultured | 9 | 2024 | 4148 | 0.240 |
Why?
| | Iodide Peroxidase | 1 | 2026 | 35 | 0.230 |
Why?
| | Signal Transduction | 7 | 2024 | 5216 | 0.230 |
Why?
| | Nanotubes, Carbon | 1 | 2025 | 46 | 0.220 |
Why?
| | Mice, Knockout | 10 | 2026 | 3124 | 0.210 |
Why?
| | Azepines | 1 | 2024 | 105 | 0.210 |
Why?
| | Heart Diseases | 2 | 2017 | 341 | 0.210 |
Why?
| | Chordata | 1 | 2023 | 5 | 0.200 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 108 | 0.200 |
Why?
| | Injections | 2 | 2025 | 199 | 0.200 |
Why?
| | Calcium Channels | 2 | 2015 | 157 | 0.200 |
Why?
| | Iron-Binding Proteins | 1 | 2023 | 43 | 0.200 |
Why?
| | Triazoles | 1 | 2024 | 187 | 0.190 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2024 | 364 | 0.190 |
Why?
| | Bone Marrow Transplantation | 2 | 2021 | 298 | 0.190 |
Why?
| | Calcium | 3 | 2015 | 1190 | 0.190 |
Why?
| | Collagen Type I | 1 | 2023 | 143 | 0.190 |
Why?
| | Arteries | 2 | 2023 | 261 | 0.180 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 297 | 0.180 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2014 | 394 | 0.180 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2013 | 46 | 0.180 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2025 | 248 | 0.180 |
Why?
| | Career Choice | 1 | 2024 | 234 | 0.170 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1957 | 0.170 |
Why?
| | Biocompatible Materials | 1 | 2025 | 429 | 0.170 |
Why?
| | Tissue Engineering | 1 | 2025 | 439 | 0.160 |
Why?
| | Phagocytes | 1 | 2021 | 80 | 0.160 |
Why?
| | Arteritis | 1 | 2020 | 23 | 0.160 |
Why?
| | Chromatin | 1 | 2024 | 553 | 0.160 |
Why?
| | Smad3 Protein | 2 | 2017 | 42 | 0.160 |
Why?
| | Treatment Failure | 1 | 2021 | 360 | 0.160 |
Why?
| | Humans | 22 | 2026 | 145475 | 0.160 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 321 | 0.150 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2021 | 138 | 0.150 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 354 | 0.150 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 187 | 0.150 |
Why?
| | Rejuvenation | 1 | 2019 | 18 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2020 | 46 | 0.150 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 192 | 0.150 |
Why?
| | Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 6 | 0.150 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2019 | 6 | 0.150 |
Why?
| | Boston | 1 | 2019 | 93 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.150 |
Why?
| | Collagen | 2 | 2019 | 457 | 0.150 |
Why?
| | Genetic Engineering | 1 | 2019 | 88 | 0.140 |
Why?
| | Cell Adhesion Molecules | 2 | 2020 | 181 | 0.140 |
Why?
| | Myoblasts, Cardiac | 2 | 2018 | 3 | 0.140 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 385 | 0.140 |
Why?
| | Heart Valve Diseases | 1 | 2020 | 151 | 0.140 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 574 | 0.140 |
Why?
| | Male | 18 | 2026 | 72843 | 0.140 |
Why?
| | Yolk Sac | 1 | 2018 | 5 | 0.140 |
Why?
| | Cell Self Renewal | 1 | 2018 | 52 | 0.140 |
Why?
| | Muscle Development | 1 | 2018 | 112 | 0.140 |
Why?
| | Cell Movement | 3 | 2018 | 959 | 0.130 |
Why?
| | Regenerative Medicine | 1 | 2018 | 48 | 0.130 |
Why?
| | Vascular Remodeling | 2 | 2021 | 209 | 0.130 |
Why?
| | Ischemia | 1 | 2021 | 422 | 0.130 |
Why?
| | Hydrogels | 1 | 2025 | 701 | 0.130 |
Why?
| | Cell Transdifferentiation | 1 | 2017 | 31 | 0.130 |
Why?
| | Smad2 Protein | 1 | 2017 | 37 | 0.130 |
Why?
| | Cicatrix | 1 | 2018 | 69 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2018 | 124 | 0.130 |
Why?
| | Cardiomegaly | 4 | 2023 | 174 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-kit | 2 | 2014 | 72 | 0.130 |
Why?
| | Models, Animal | 1 | 2018 | 393 | 0.120 |
Why?
| | Actin Cytoskeleton | 2 | 2015 | 103 | 0.120 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2016 | 10 | 0.120 |
Why?
| | Isoproterenol | 1 | 2016 | 96 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2022 | 2803 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2016 | 98 | 0.120 |
Why?
| | CX3C Chemokine Receptor 1 | 2 | 2026 | 19 | 0.120 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 66 | 0.110 |
Why?
| | Enzyme Activation | 2 | 2014 | 762 | 0.110 |
Why?
| | Aorta, Thoracic | 2 | 2015 | 286 | 0.110 |
Why?
| | Chronic Disease | 1 | 2021 | 1808 | 0.110 |
Why?
| | Nanoparticles | 1 | 2021 | 517 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 2 | 2013 | 981 | 0.110 |
Why?
| | Muscle Proteins | 1 | 2016 | 242 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 474 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2019 | 756 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2016 | 307 | 0.100 |
Why?
| | Aortic Diseases | 1 | 2015 | 125 | 0.100 |
Why?
| | Melanosomes | 1 | 2014 | 2 | 0.100 |
Why?
| | Concanavalin A | 1 | 2014 | 72 | 0.100 |
Why?
| | Pigment Epithelium of Eye | 1 | 2014 | 36 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2015 | 397 | 0.100 |
Why?
| | Heart Injuries | 1 | 2014 | 42 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2016 | 588 | 0.100 |
Why?
| | Phenylurea Compounds | 1 | 2014 | 119 | 0.100 |
Why?
| | Niacinamide | 1 | 2014 | 104 | 0.100 |
Why?
| | Chemokine CCL2 | 2 | 2026 | 112 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 198 | 0.090 |
Why?
| | Cation Transport Proteins | 1 | 2013 | 118 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 264 | 0.090 |
Why?
| | Small Molecule Libraries | 1 | 2013 | 111 | 0.090 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 221 | 0.090 |
Why?
| | Cell Proliferation | 5 | 2020 | 2507 | 0.090 |
Why?
| | Heart Rupture | 1 | 2011 | 5 | 0.090 |
Why?
| | Cell Death | 1 | 2013 | 382 | 0.090 |
Why?
| | Female | 9 | 2026 | 78845 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2015 | 409 | 0.090 |
Why?
| | Sarcopenia | 1 | 2013 | 91 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 847 | 0.080 |
Why?
| | Cyclophilins | 1 | 2010 | 40 | 0.080 |
Why?
| | Acute Coronary Syndrome | 1 | 2013 | 297 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2021 | 11772 | 0.070 |
Why?
| | Single-Cell Analysis | 2 | 2024 | 362 | 0.070 |
Why?
| | Indoles | 2 | 2013 | 507 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 220 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2009 | 192 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2013 | 935 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2026 | 2597 | 0.060 |
Why?
| | Primary Cell Culture | 2 | 2019 | 172 | 0.060 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2026 | 20 | 0.060 |
Why?
| | Receptors, CCR2 | 1 | 2026 | 39 | 0.060 |
Why?
| | Phenotype | 3 | 2024 | 3155 | 0.060 |
Why?
| | Triiodothyronine | 1 | 2026 | 54 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2020 | 891 | 0.060 |
Why?
| | Cell Fusion | 2 | 2016 | 48 | 0.060 |
Why?
| | Hematopoietic Stem Cells | 2 | 2020 | 435 | 0.060 |
Why?
| | Endothelial Cells | 3 | 2019 | 874 | 0.060 |
Why?
| | Thyroid Hormones | 1 | 2026 | 68 | 0.060 |
Why?
| | Transcription Factor RelA | 1 | 2024 | 86 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2878 | 0.050 |
Why?
| | Lipoylation | 1 | 2023 | 17 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 381 | 0.050 |
Why?
| | Histidine | 1 | 2023 | 66 | 0.050 |
Why?
| | Materials Testing | 1 | 2025 | 345 | 0.050 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2023 | 56 | 0.050 |
Why?
| | Neuropeptides | 1 | 2023 | 75 | 0.050 |
Why?
| | Acyltransferases | 1 | 2023 | 78 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 1 | 2024 | 191 | 0.050 |
Why?
| | Echocardiography | 2 | 2021 | 647 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1767 | 0.050 |
Why?
| | Heart Atria | 1 | 2023 | 141 | 0.050 |
Why?
| | Rats | 3 | 2019 | 5584 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2214 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2024 | 389 | 0.050 |
Why?
| | Temperature | 1 | 2025 | 633 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 273 | 0.040 |
Why?
| | Acclimatization | 1 | 2023 | 170 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2013 | 74 | 0.040 |
Why?
| | Theranostic Nanomedicine | 1 | 2021 | 15 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 666 | 0.040 |
Why?
| | Airway Remodeling | 1 | 2021 | 63 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 149 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 523 | 0.040 |
Why?
| | Transplantation Chimera | 1 | 2020 | 57 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 2 | 2013 | 138 | 0.040 |
Why?
| | Fibrillin-1 | 1 | 2020 | 6 | 0.040 |
Why?
| | Drug Carriers | 1 | 2021 | 136 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 207 | 0.040 |
Why?
| | Hypertrophy | 1 | 2020 | 128 | 0.040 |
Why?
| | Angiotensin II | 1 | 2020 | 101 | 0.040 |
Why?
| | Disease Progression | 2 | 2020 | 2864 | 0.040 |
Why?
| | Multiprotein Complexes | 2 | 2013 | 172 | 0.040 |
Why?
| | Sarcoglycans | 1 | 2019 | 5 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2020 | 87 | 0.040 |
Why?
| | Adipokines | 1 | 2020 | 57 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 344 | 0.040 |
Why?
| | Mitral Valve | 1 | 2020 | 95 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 316 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2105 | 0.040 |
Why?
| | Bone Marrow | 1 | 2020 | 306 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 532 | 0.040 |
Why?
| | Dogs | 1 | 2020 | 458 | 0.030 |
Why?
| | Blood Circulation | 1 | 2018 | 44 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 679 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 442 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 454 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 381 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2017 | 55 | 0.030 |
Why?
| | Swine | 1 | 2020 | 825 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 234 | 0.030 |
Why?
| | Mice, Inbred mdx | 1 | 2016 | 12 | 0.030 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 156 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 309 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2018 | 319 | 0.030 |
Why?
| | Catecholamines | 1 | 2016 | 88 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2016 | 84 | 0.030 |
Why?
| | Muscle, Skeletal | 2 | 2019 | 1789 | 0.030 |
Why?
| | Protein Phosphatase 2C | 1 | 2015 | 15 | 0.030 |
Why?
| | Time Factors | 2 | 2018 | 7123 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2440 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2015 | 61 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2015 | 93 | 0.030 |
Why?
| | Ventricular Myosins | 1 | 2015 | 39 | 0.030 |
Why?
| | Myofibrils | 1 | 2015 | 49 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 910 | 0.030 |
Why?
| | Sarcomeres | 1 | 2015 | 97 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 212 | 0.030 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 61 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 1023 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2015 | 135 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2014 | 119 | 0.030 |
Why?
| | Metoprolol | 1 | 2014 | 26 | 0.030 |
Why?
| | Cytoplasmic Streaming | 1 | 2014 | 2 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2014 | 74 | 0.030 |
Why?
| | Cell Aggregation | 1 | 2014 | 19 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 266 | 0.030 |
Why?
| | Perciformes | 1 | 2014 | 20 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2823 | 0.030 |
Why?
| | Cats | 1 | 2014 | 231 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 270 | 0.020 |
Why?
| | Integrases | 1 | 2014 | 122 | 0.020 |
Why?
| | Tamoxifen | 1 | 2014 | 191 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 219 | 0.020 |
Why?
| | Maleimides | 1 | 2013 | 21 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2015 | 449 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 500 | 0.020 |
Why?
| | Everolimus | 1 | 2013 | 112 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 204 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1048 | 0.020 |
Why?
| | HeLa Cells | 1 | 2013 | 632 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2015 | 443 | 0.020 |
Why?
| | Hepatocytes | 1 | 2013 | 224 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 637 | 0.020 |
Why?
| | Cardiotonic Agents | 1 | 2011 | 94 | 0.020 |
Why?
| | Sirolimus | 1 | 2013 | 280 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1707 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 187 | 0.020 |
Why?
| | Death | 1 | 2011 | 132 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 226 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 291 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1310 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 969 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1716 | 0.020 |
Why?
| | Bone and Bones | 1 | 2013 | 317 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4295 | 0.020 |
Why?
| | Mitochondria, Heart | 1 | 2010 | 107 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.020 |
Why?
| | Knee Joint | 1 | 2013 | 428 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 90 | 0.020 |
Why?
| | Myosin Heavy Chains | 1 | 2010 | 183 | 0.020 |
Why?
| | Exons | 1 | 2010 | 363 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2010 | 216 | 0.020 |
Why?
| | Cell Division | 1 | 2010 | 756 | 0.020 |
Why?
| | Capillaries | 1 | 2009 | 125 | 0.020 |
Why?
| | DNA | 1 | 2014 | 1435 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2238 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 1764 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1100 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1082 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1246 | 0.010 |
Why?
| | Liver | 1 | 2013 | 1896 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2524 | 0.010 |
Why?
| | Adult | 1 | 2023 | 40777 | 0.010 |
Why?
| | Aged | 1 | 2014 | 26153 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 36215 | 0.010 |
Why?
|
|
Vagnozzi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|